Prostate cancer is a common cancer that affects men. It is the second leading cause of cancer death in men in the United States, after lung cancer. In 2021, it is estimated that there will be over 248,000 new cases of prostate cancer and over 34,000 deaths from the disease. Prostate cancer is most common in older men, with the average age at diagnosis being 66. However, it can occur in men of any age.

Treatment options for prostate cancer depend on the stage of the disease. For early-stage prostate cancer, treatment options may include surgery, radiation therapy, and active surveillance. For advanced prostate cancer, treatment options may include hormone therapy, chemotherapy, and immunotherapy.

There is hope for the future of prostate cancer treatment. Researchers are developing new treatments that are more effective and have fewer side effects. These treatments include targeted therapy, gene therapy, and immunotherapy. These treatments are showing promise in clinical trials, and they may one day be the standard of care for prostate cancer.